Skip to main content

Table 1 Criteria, case–control distribution and association between MetS and PCa, according to different MetS definitions

From: Metabolic syndrome and prostate cancer risk in a population-based case–control study in Montreal, Canada

MetS Definition Criteria used in the study Cases (N = 1937) Controls (N = 1995) ORa CI 95 %
N % n %
NCEP-ATPIII At least 3 of these conditions: 476 24.9 629 31.8 0.70 0.60-0.82
- Dyslipidemia (counting for 2 conditions: low HDL-C and high TG)
- Type 2 diabetes
- Hypertension
- WC > 102 cm (or BMI > 30)
NCEP-ATPIII ico NCEP-ATPIII criteria with waist-to-height ratio > 0.5 instead of WC > 102 cm 579 30.3 734 37.2 0.71 0.61-0.82
WHO Type 2 diabetes + 2 other conditions among them: 149 7.8 279 14.1 0.54 0.44-0.68
- Hypertension
- BMI > 30 or waist-to-hip ratio > 0.9
- Dyslipidemia (as a simple condition)
IDF - WC > 90 cm for Asiatic men and > 94 cm for others (or BMI > 30) + 2 other conditions among them: 427 22.3 527 26.6 0.75 0.64-0.88
- Type 2 diabetes
- Hypertension
- Dyslipidemia (counting for 2 conditions: low HDL-C and high TG)
  1. aAdjusted for age, family history of prostate cancer, ancestry, prostate cancer screening and family income.BMI, Body mass index; CI, Confidence interval; HDL-C, High-density lipoprotein cholesterol; IDF, International Diabetes Federation; NCEP-ATPIII, Adult Treatment Panel III from the National Cholesterol Education Program; OR, Odds ratio; TG: Triglycerides; WC, Waist circumference; WHO: World Health Organization